Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$7.2 - $10.05 $1,440 - $2,010
-200 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$7.25 - $15.65 $1,450 - $3,130
-200 Reduced 50.0%
200 $2,000
Q3 2017

Nov 15, 2017

SELL
$12.0 - $15.0 $1,200 - $1,500
-100 Reduced 20.0%
400 $6,000
Q2 2017

Aug 15, 2017

BUY
N/A
500
500 $6,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.